James Bligh

Insider Reports History

Entity
Individual
Location
38 Oxberry Avenue, London, United Kingdom
Signature
/s/ James Bligh
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Bligh:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CONDUIT PHARMACEUTICALS INC. Interim CFO, Director Stock Option (Right to Buy) 1.89M $174K $0.09 Nov 18, 2024 Direct
CONDUIT PHARMACEUTICALS INC. Interim CFO, Director Common Stock 37.3K $9.63K $0.26 Jun 11, 2024 Direct

Insider Reports Filed by James Bligh

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CDT CONDUIT PHARMACEUTICALS INC. Nov 18, 2024 1 $174K 4 Nov 20, 2024 Interim CFO, Director
CDT CONDUIT PHARMACEUTICALS INC. Jun 11, 2024 1 $0 4 Jun 11, 2024 Interim CFO, Director
CDT CONDUIT PHARMACEUTICALS INC. Dec 1, 2023 1 $1.23M 4 Dec 5, 2023 Director
MURF CONDUIT PHARMACEUTICALS INC. Sep 22, 2023 0 $0 3 Sep 26, 2023 Director